May 2, 2016 – In order to make reasonable coverage decisions about new medicines, payers need access to information from drug companies about those medicines prior to their FDA approval, a practice that currently is restricted under FDA policy, according to a recent blog post in The Catalyst, a Pharmaceutical Research and Manufacturers of America […]
Read more